Zeitungsständer (Symbolbild).
Quelle: - © Global_Pics / iStock Unreleased / Getty Images:
Google
dpa-AFX  | 
aufrufe Aufrufe: 42

Original-Research: Deutsche Beteiligungs AG (von NuWays AG): BUY

Original-Research: Deutsche Beteiligungs AG - from NuWays AG

play Anhören
share Teilen
feedback Feedback
copy Kopieren
newsletter
font_big Schrift vergrößern
Dt. Beteiligungs AG 25,60 € Deutsche Beteiligungs AG Chart +0,39%
Zugehörige Wertpapiere:

19.01.2026 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Deutsche Beteiligungs AG

Company Name: Deutsche Beteiligungs AG

ISIN: DE000A1TNUT7

Reason for the research: Update

Recommendation: BUY

Target price: EUR 39

Target price on sight of: 12 months

Last rating change:

Analyst: Christian Sandherr

Looking into FY26: High deal activity expected

Increased deal activity expected. As highlighted during the company's Q3

earnings call, the CEO reiterated expectations for elevated deal activity

over the coming twelve months, with targeted divestments of up to 20% of

NAV. In our view, the strategic focus should primarily lie on assets held

within the older DBAG VI fund, of which four investments remain. DBAG VI was

launched in 2013 and has effectively reached the end of its fund life,

implying that no further management fees are being generated. Against this

backdrop, fund investors are likely to increasingly expect realizations and

capital distributions, which should further incentivize an accelerated exit

pace.

Assuming an average valuation uplift of at least 15-20% versus NAV (eNuW),

DBAG should be able to generate meaningful income from investment activity.

Moreover, the divestment of mature assets and the resulting capital returns

would, in our view, create a solid foundation for the launch of a new fund,

both in terms of track record and investor confidence.

Raising additional funds. Looking ahead, we believe DBAG could consider

raising DBAG IX as a successor to DBAG VIII. The exact timing is likely to

depend on the group's divestment momentum, as a number of existing investors

may be inclined to roll over committed capital into a new vintage. A

successful fundraise would not only increase DBAG's financial firepower for

future investments but should also provide a structural uplift to fund

services earnings. In this context, we estimate an incremental contribution

to fund services EBITA of around EUR 2-3m p.a. reflecting a 15-20% increase

(eNuW).

Further, we also see the possibility for a second continuation fund. Mind

you, the group's current continuation fund (single-asset fund to hold an

asset beyond the original fund life, while giving LPs a liquidity option),

which was launched in 2024 with a volume of EUR 130m is fully invested,

holding the portfolio company Solvares.

Continued high shareholder returns. DBAG also appears well positioned to

maintain its shareholder-friendly capital allocation policy. We expect the

company to continue paying a base dividend (eNuW: EUR 1.00 per share, a yield

of c. 4%). In addition, DBAG is currently executing a EUR 20m share buyback

program. With roughly six weeks remaining, we estimate that some EUR 6m could

still be outstanding at the end. Given the shares' persistent and still

significant discount to NAV, we would view the launch of a subsequent

buyback program as sensible from a capital allocation perspective.

We confirm our BUY rating with an unchanged EUR 39 PT based on SOTP (DCF for

Fund Services + discount to our NAV per share estimate at year-end).

You can download the research here:

https://eqs-cockpit.com/c/fncls.ssp?u=95d5211f08171ad26d3c18ff7b53e612

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.


The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

View original content:

https://eqs-news.com/?origin_id=7a2242a3-f508-11f0-8534-027f3c38b923&lang=en


2261804 19.01.2026 CET/CEST

°

Für dich aus unserer Redaktion zusammengestellt

Dein Kommentar zum Artikel im Forum

Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Themen im Trend